[1] Lockshin MD, Reinitz E, Druzin ML, et al. Lupus pregnancy. Case control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med, 1984,77:893-898.
[2] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index of lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992,35:630-640
[3] 郑敏,朱铁城. SLE患者 B淋巴细胞增殖功能测定及其临床意义.中华皮肤科杂志,1990, 23:90-92.
[4] Ohsako S, Hara M, Harigai M, et al. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immuno pathol, 1994,73:109-114.
[5] Lorenz HM, Grunke M, Hieronymus T, et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum, 1997,40:306-317.
[6] 蒋莉,赵丽娟,何春涤. 系统性红斑狼疮患者 T淋巴细胞亚群 Fas及 bcl-2抗原的表达.中华皮肤科杂志,1998, 31: 4-5.
[7] 刘亚光,尹培达,石成钢,等.系统性红斑狼疮患者外周血淋巴细胞 bcl-2的表达及临床意义.中华皮肤科杂志,1999, 32:9-11.
[8] Mehrian R,Quismorio FP Jr,Strassmann G, et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibi lity to systemic lupus erythematosus. Arthritis Rheum, 1998,41:596-602. |
